Search clinical trials for: Vesicular monoamine transporter 2 (VMAT2) inhibitor
Total 104383 results
-
University of WashingtonGilead Sciences; Clinique des Maladies Infectieuses Ibrahima DIOP Mar/CRCF,...Completed
-
Eisai Co., Ltd.CompletedNeoplasms | Carcinoma | Neoplasms, Glandular and Epithelial | Carcinoma, HepatocellularJapan
-
Eisai Co., Ltd.Completed
-
University Hospital, Strasbourg, FranceRecruitingAdult ADHD | Adult-onset ADHD With Mood DisorderFrance
-
BioCryst PharmaceuticalsTerminatedImmunoglobulin A Nephropathy | Membranous Nephropathy | Complement 3 GlomerulopathyFrance, Italy, Spain, United Kingdom
-
RedHill Biopharma LimitedActive, not recruitingLung Diseases | Bronchiectasis | Pulmonary Mycobacterium Avium Complex InfectionUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedNon Small Cell Lung CancerUnited States, Poland, Germany, Russian Federation, Latvia, Ukraine
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic ControlGermany, Slovakia, Czechia, Hungary, Poland
-
AstraZenecaAstra Zeneca, Bristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic Control | High HbA1c LevelCzech Republic, Poland, Spain, Germany, Canada, Slovakia
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisSpain, Czechia, Bulgaria, Serbia, Russian Federation, Ukraine, Poland, Slovakia
-
Eisai Inc.Completed
-
Mochida Pharmaceutical Company, Ltd.CompletedSteatohepatitisUnited States, Puerto Rico
-
Poniard PharmaceuticalsUnknown
-
Kaiser PermanentePatient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaboratorsRecruitingCardiovascular Diseases | Type 2 Diabetes MellitusUnited States
-
Samsun UniversityRecruiting
-
Boehringer IngelheimCompleted
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic ControlUnited States, Canada, Czechia, Germany, Russian Federation, Mexico
-
Orum Therapeutics USA, Inc.RecruitingHER2-positive Breast Cancer | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein OverexpressionUnited States
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Italy, Spain, Sweden, Canada, Bulgaria, Poland, Czechia
-
University of WashingtonNational Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp... and other collaboratorsTerminated
-
BiotestCompletedRheumatoid ArthritisPoland, Czech Republic, Germany, Hungary, Italy, Latvia, Spain
-
George Washington UniversityJanssen Scientific Affairs, LLCCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaParexelCompletedHealthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)Germany
-
Centre Hospitalier Régional d'OrléansCompleted
-
Caroline M KistorpRigshospitalet, Denmark; Herlev and Gentofte Hospital; Danish Heart FoundationCompletedType2 Diabetes MellitusDenmark
-
Centre Hospitalier Universitaire DijonCompletedType-2 Diabetes | Oral AntidiabeticsFrance
-
UCB PharmaParexelCompletedHealthy Subjects | Renal ImpairmentsJapan
-
Theravance BiopharmaTerminatedUlcerative Colitis (UC)United States, Australia, Bulgaria, Canada, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Poland, Portugal, Romania, Serbia, Slovakia, South Africa, Spain, Taiwan, Ukraine
-
University of RostockUnknownAcute Kidney Injury | Renal Replacement TherapyGermany
-
AVEO Pharmaceuticals, Inc.CompletedMultiple Myeloma | Lymphomas | Malignant Solid TumorUnited States
-
University Hospital, BordeauxIpsenCompleted
-
Zhujiang HospitalThird Affiliated Hospital, Sun Yat-Sen University; Peking University Shenzhen... and other collaboratorsCompletedType 2 Diabetes MellitusChina
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, Bulgaria, Czech Republic, Hungary, Poland
-
University Hospital, GrenobleCompletedAdrenergic Beta-2 Agonist Effect | Albuterol EffectFrance
-
Rexahn Pharmaceuticals, Inc.CompletedMajor Depressive DisorderUnited States
-
Centro Universitario de Ciencias de la Salud, MexicoActive, not recruitingDiabetes Mellitus Type 2 Without ComplicationMexico
-
UCB BIOSCIENCES GmbHCompleted
-
Columbia UniversityUniversitat Autonoma de Barcelona; Instituto de Salud Carlos III; University... and other collaboratorsActive, not recruitingThymidine Kinase 2 Deficiency | Mitochondrial DNA Depletion Syndrome 2 Myopathic TypeUnited States
-
Bangkok Metropolitan Administration Medical College...Completed
-
University of Rome Tor VergataCompletedLiver Transplantation | SARS-CoV-2 VaccinationItaly
-
Merck Sharp & Dohme LLCCompletedCancers Expressing HER-2 and/or CEA
-
Fondazione SchenaUniversity of BariRecruitingGlomerulonephritis | Immunoglobulin A NephropathyItaly
-
Novartis PharmaceuticalsCompletedHematologic NeoplasmsIsrael, United States, Netherlands, Spain
-
BioCryst PharmaceuticalsActive, not recruitingHereditary Angioedema | PediatricSpain, Austria, Canada, France, Germany, Israel, Italy, Poland, Romania, United Kingdom
-
Humanis Saglık Anonim SirketiCompleted
-
University of PisaCompletedType2 Diabetes MellitusItaly
-
Hadassah Medical OrganizationUnknownDiabetes Type Two
-
D3 Bio (Wuxi) Co., LtdRecruitingHER-2 Positive Advanced Solid TumorsAustralia, United States, China